Comparison
2 3 Layered Lissencephaly C5139357 vs 16p12 2 Microdeletion Syndrome C4708497
Clinical comparison between 2 3 Layered Lissencephaly and 16p12 2 Microdeletion Syndrome for differential diagnosis and treatment planning.
2 3 Layered Lissencephaly C5139357
A brain malformation where the cerebral cortex develops abnormally with fewer layers. Causes severe developmental delays, seizures, and motor problems. Treatment involves seizure management and developmental support.
16p12 2 Microdeletion Syndrome C4708497
A rare genetic condition where a small piece of chromosome 16 is missing. It can cause developmental delays, intellectual disability, and recurrent infections in some individuals. Treatment involves supportive therapies and medical management of symptoms.
6 comparison axes
Onset
2 3 Layered Lissencephaly C5139357
0-1
16p12 2 Microdeletion Syndrome C4708497
0-5
Onset patterns differ
Severity
2 3 Layered Lissencephaly C5139357
severe
16p12 2 Microdeletion Syndrome C4708497
moderate
Different severity levels
Chronic
2 3 Layered Lissencephaly C5139357
Chronic
16p12 2 Microdeletion Syndrome C4708497
Chronic
Differing course
Communicable
2 3 Layered Lissencephaly C5139357
No
16p12 2 Microdeletion Syndrome C4708497
No
Different transmission
Body System
2 3 Layered Lissencephaly C5139357
neurologic
16p12 2 Microdeletion Syndrome C4708497
congenital
Same/different system
Category
2 3 Layered Lissencephaly C5139357
neurologic
16p12 2 Microdeletion Syndrome C4708497
genetic
Different category
Bottom line
2-3-layered-lissencephaly-C5139357 and 16p12-2-microdeletion-syndrome-C4708497 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2 3 Layered Lissencephaly C5139357 | 16p12 2 Microdeletion Syndrome C4708497 | Discriminating power |
|---|---|---|---|
| Seizures | Often prominent with the cortical malformation, though frequency is not established here. | Not a defining feature in the supplied description. | Moderate |
| Motor impairment | Severe motor problems are described. | Motor findings are not specifically established in the source. | Moderate |
| Recurrent infections | Not described as a characteristic feature. | May occur in some individuals. | Moderate |
When to favor each condition
Choose 2 3 Layered Lissencephaly C5139357 when
Imaging suggests an abnormally layered cerebral cortex
The diagnosis centers on a structural brain malformation.
High
Severe early neurologic impairment with seizures
This pattern fits the supplied neurologic description better.
Moderate
No chromosomal deletion is identified
Absence of 16p12.2 deletion does not prove lissencephaly, but shifts evaluation toward brain imaging.
Low
Choose 16p12 2 Microdeletion Syndrome C4708497 when
Chromosomal microarray finds a 16p12.2 deletion
Genetic testing directly supports the microdeletion diagnosis.
High
Developmental delay with intellectual disability and infections
This combination matches the supplied syndrome description.
Moderate
Brain imaging does not show lissencephaly
Normal cortical layering makes the left condition unlikely but does not exclude other causes.
Moderate
How key tests differ
| Test | 2 3 Layered Lissencephaly C5139357 | 16p12 2 Microdeletion Syndrome C4708497 | Interpretation |
|---|---|---|---|
| Brain MRI | Abnormal cortical development with reduced layering may be seen. | No specific MRI pattern is established by the source. | MRI supports a structural diagnosis but needs specialist review. |
| Chromosomal microarray | No single chromosomal result is established here. | May identify deletion of chromosome 16p12.2. | A confirmed deletion supports the right diagnosis. |
| Clinical neurologic assessment | Severe developmental, seizure, and motor concerns are described. | Developmental delay and intellectual disability may be present. | Assessment guides care but cannot replace confirmatory testing. |
Prognosis comparison
2 3 Layered Lissencephaly C5139357
- Outcome
- Often severe neurologic disability is described, but individual outcome is not established.
- Factors
- Seizure burden, motor impairment, and developmental support may influence course.
16p12 2 Microdeletion Syndrome C4708497
- Outcome
- Generally described as moderate, with variable developmental and medical effects.
- Factors
- Degree of developmental disability, infections, and available supportive care may matter.
Time frame: Both are chronic conditions, commonly recognized in early childhood.
Prognosis should be individualized; no mortality or exact outcome data are supplied.
Complications comparison
| Complication | Presentation |
|---|---|
| Seizure-related complications | Seizures are described and may require ongoing management. Not established as characteristic from the source. Risk and severity vary; exact outcomes are not supplied. |
| Developmental disability | Severe developmental delay is described. Developmental delay and intellectual disability may occur. Individual function cannot be predicted from these descriptions alone. |
| Recurrent infection | Not described. May affect some individuals and need medical management. Infection type, frequency, and immune findings are not established here. |
Patient education highlights
- HighDifferent causes
One is a brain-structure malformation; the other is a missing chromosomal segment. Testing determines which applies.
- HighSupportive care
Care may include seizure management, developmental therapies, and treatment of infections or other symptoms.
- MediumVariable course
Severity and needs differ among individuals. A clinician should interpret results and prognosis.